CRBU
Income statement / Annual
Last year (2023), Caribou Biosciences, Inc.'s total revenue was $34.48 M,
an increase of 148.91% from the previous year.
In 2023, Caribou Biosciences, Inc.'s net income was -$102.07 M.
See Caribou Biosciences, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$34.48 M
|
$13.85 M
|
$9.60 M
|
$12.36 M
|
$5.79 M
|
| Cost of Revenue |
$112.08 M |
$3.64 M |
$984,000.00 |
$34.43 M |
$23.64 M |
| Gross Profit |
-$77.60 M |
$10.21 M |
$8.61 M |
-$22.06 M |
-$17.85 M |
| Gross Profit Ratio |
-2.25 |
0.74 |
0.9 |
-1.78 |
-3.08 |
| Research and Development
Expenses |
$112.08 M
|
$82.23 M
|
$52.26 M
|
$34.43 M
|
$23.64 M
|
| General & Administrative
Expenses |
$38.46 M
|
$38.02 M
|
$24.32 M
|
$14.06 M
|
$16.46 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$38.46 M
|
$38.02 M
|
$24.32 M
|
$14.06 M
|
$16.46 M
|
| Other Expenses |
$0.00 |
$7.18 M |
-$1.35 M |
$514,000.00 |
$0.00 |
| Operating Expenses |
$150.54 M |
$120.25 M |
$76.58 M |
$48.49 M |
$40.09 M |
| Cost And Expenses |
$150.54 M |
$120.25 M |
$76.58 M |
$48.49 M |
$40.09 M |
| Interest Income |
$10.70 M |
$4.60 M |
$148,000.00 |
$236,000.00 |
$1.05 M |
| Interest Expense |
$0.00 |
$0.00 |
$8,000.00 |
$20,000.00 |
$4,000.00 |
| Depreciation &
Amortization |
$3.53 M
|
$3.64 M
|
$984,000.00
|
$900,000.00
|
$751,000.00
|
| EBITDA |
-$112.53 M
|
-$104.78 M
|
-$66.00 M
|
-$35.21 M
|
-$30.21 M
|
| EBITDA Ratio |
-3.26 |
-7.67 |
-7.1 |
-2.79 |
-5.62 |
| Operating Income Ratio
|
-3.37
|
-7.68
|
-6.98
|
-2.92
|
-5.93
|
| Total Other
Income/Expenses Net |
$14.18 M
|
$7.05 M
|
$377,000.00
|
-$3,000.00
|
$3.34 M
|
| Income Before Tax |
-$101.88 M |
-$99.35 M |
-$66.60 M |
-$36.13 M |
-$30.97 M |
| Income Before Tax Ratio
|
-2.95
|
-7.17
|
-6.94
|
-2.92
|
-5.35
|
| Income Tax Expense |
$193,000.00 |
$70,000.00 |
$321,000.00 |
-$1.82 M |
-$7.54 M |
| Net Income |
-$102.07 M |
-$99.42 M |
-$66.92 M |
-$34.31 M |
-$23.43 M |
| Net Income Ratio |
-2.96 |
-7.18 |
-6.97 |
-2.78 |
-4.05 |
| EPS |
-1.38 |
-1.64 |
-1.11 |
-0.57 |
-0.39 |
| EPS Diluted |
-1.38 |
-1.64 |
-1.11 |
-0.57 |
-0.39 |
| Weighted Average Shares
Out |
$73.81 M
|
$60.80 M
|
$60.26 M
|
$59.97 M
|
$59.97 M
|
| Weighted Average Shares
Out Diluted |
$73.81 M
|
$60.80 M
|
$60.26 M
|
$59.97 M
|
$59.97 M
|
| Link |
|
|
|
|
|
